기업개요(ETF)
The ARK Genomic Revolution Multi-Sector ETF is an actively managed fund that targets companies involved in the genomics industry. ARKG reaches across multiple sectors and geographies for companies that the advisor believes will benefit from innovations in the genomics-related industry. The reality is almost all of its holdings are in US healthcare-related companies, with biotech naturally leading the way. This is a niche fund that charges a high fee for its actively managed strategy. Because it doesn’t match well with our biotech benchmark, investors should look closely at where the fund makes its bets. It is an interesting concept and there is good performance potential, but the fund's growth has been lackluster since inception. Liquidity is thin and spreads are often wide. Interested block traders will most likely have to work with the issuer, as underlying liquidity is lacking. The fund charges a high fee, though typical for an actively managed fund, and investors should consider closure risk before jumping in. ARKG reaches across multiple sectors and geographies for companies that the advisor believes will benefit from innovations in the genomics-related industry. The reality is almost all of its holdings are in US healthcare-related companies, with biotech naturally leading the way. This is a niche fund that charges a high fee for its actively managed strategy. Because it doesn’t match well with our biotech benchmark, investors should look closely at where the fund makes its bets. It is an interesting concept and there is good performance potential, but the fund's growth has been lackluster since inception. Liquidity is thin and spreads are often wide. Interested block traders will most likely have to work with the issuer, as underlying liquidity is lacking. The fund charges a high fee, though typical for an actively managed fund, and investors should consider closure risk before jumping in.
